Drug Search Results

Pristinamycin

Alternative Names: pristinamycin
Latest Update: 2024-11-14
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Pristinamycin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Pneumonia

Phase 3: Tonsillitis

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
PRISTL06562	P4	Terminated	Pneumonia	2023-02-20
PRI-angine	P3	Completed	Tonsillitis	2008-03-01

Recent News Events

Date	Type	Title
04/17/2024	PubMed	Antimicrobial resistance of genital mycoplasmas recovered from nonpregnant women in Greece: trends over the last 15 years.
04/08/2024	PubMed	Cross-reactivity among and between macrolides, lincosamides, and streptogramins: Study on the French pharmacovigilance database.
04/05/2024	PubMed	Effects of S-adenosylmethionine on AfsKRS regulation in pristinamycin biosynthesis in Streptomyces pristinaespiralis.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions